🇺🇸 FDA
Pipeline program

Biktarvy 50 mg/200 mg/25 mg film-coated tablets, Descovy 200 mg/25 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Pifeltro 100 mg film-coated tablets

DORALI

Approved small_molecule active

Quick answer

Biktarvy 50 mg/200 mg/25 mg film-coated tablets, Descovy 200 mg/25 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Pifeltro 100 mg film-coated tablets for Human Immunodeficiency Virus is a Approved program (small_molecule) at Meda AB with 1 ClinicalTrials.gov record(s).

Program details

Company
Meda AB
Indication
Human Immunodeficiency Virus
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials